Status:
RECRUITING
Investıgatıon Of The Effectıveness Of The Mollıı Suıt In Chıldren Wıth Ambulatory Cerebral Palsy
Lead Sponsor:
Kastamonu University
Collaborating Sponsors:
Gazi University
Conditions:
Cerebral Palsy
Spasticity, Muscle
Eligibility:
All Genders
4-18 years
Phase:
NA
Brief Summary
Cerebral Palsy (CP) is the most common developmental disorder in childhood. Individuals' independence in daily living activities and participation in education, games, social and community activities ...
Detailed Description
Cerebral Palsy (CP) is the most common developmental disorder in childhood and is an umbrella term covering a heterogeneous group of permanent but unchanging movement and posture disorders caused by d...
Eligibility Criteria
Inclusion
- Being a voluntary participant in the study,
- Having a diagnosis of spastic CP,
- Being between 1-3 on the Gross Motor Classification System (GMFCS),
- Being between the ages of 4 and 18,
- Being able to express pain and discomfort
Exclusion
- Being between 4-5 on Gross Motor Classification System (GMFCS)
- Having Botolunim Toxin A application before 3 months
- Having a surgical intervention before 6 months
- Having a shunt or an invasive medical pump (baclofen, insulin, etc.)
Key Trial Info
Start Date :
November 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 5 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06109129
Start Date
November 5 2023
End Date
November 5 2025
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University
Ankara, Turkey (Türkiye)